EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Purine and Pyrrolopyrimidine‐Based Small Molecules as Multitarget Therapeutics

Federica Borghi iD, Antonio Laus, Claudia Sorbi, Giulio Rastelli

Archiv der Pharmazie · 2026-06 · 359 (6)

DOI: 10.1002/ardp.70296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 09.07.2026. Verfasst von Federica Borghi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science (DSV), University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Pyrimidines, Purines, Pyrroles. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Italiana per la Ricerca sul Cancro, European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR Mission 4 - Component 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purines and pyrrolo[2,3‐ d ]pyrimidines are privileged heterocyclic scaffolds widely represented in small molecules targeting a broad range of therapeutically relevant targets, including kinases, folate‐metabolizing enzymes, histone deacetylases (HDACs), bromodomain containing proteins, membrane transporters, phosphodiesterases (PDEs), ion channels, and toll‐like receptors (TLRs). While these scaffolds have been extensively investigated in medicinal chemistry, their role in multitarget drug design has received comparatively less attention. This review provides a comprehensive overview of purine‐ and pyrrolopyrimidine‐based compounds reported over the last two decades from a multitarget medicinal chemistry perspective, with particular emphasis on the design principles and SAR underlying simultaneous modulation of multiple biological targets. By systematically comparing compounds across different target classes, we highlight the key structural features responsible for multitarget activity and discuss how specific scaffold modifications influence potency, selectivity, and polypharmacological profiles. Representative examples are presented to illustrate the successful application of these scaffolds in the development of dual‐ and multitarget inhibitors with promising anticancer, anti‐inflammatory, and drug resistance‐overcoming activities. Particular attention is devoted to compounds capable of overcoming drug resistance through the simultaneous modulation of complementary biological pathways. Overall, this review provides an integrated medicinal chemistry framework for understanding multitarget purine‐ and pyrrolopyrimidine‐based ligands and identifies emerging opportunities and challenges for the development of next‐generation polypharmacological agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPurinesPyrrolesHumansStructure-Activity RelationshipDrug DesignAntineoplastic AgentsAnimalsMolecular StructureAnti-Inflammatory Agents

Stichwörter der Autor:innen

drug designpolypharmacologypurinespyrrolopyrimidinesstructure–activity relationships

Substanzen

PyrimidinespyrrolopyrimidinePurinesPyrrolesAntineoplastic AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Life Science (DSV), University of Modena and Reggio Emilia, Modena, Italy.
  • Center for Advanced Studies Research and Development in Sardinia (CRS4), Pula, Italy.

ORCID-Profile: Federica Borghi

Förderung

  • Fondazione Italiana per la Ricerca sul Cancro
  • European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR Mission 4 - Component 2

Zitieren

APA

Borghi, F., Laus, A., Sorbi, C., & Rastelli, G. (2026). Purine and Pyrrolopyrimidine‐Based Small Molecules as Multitarget Therapeutics. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70296

Vancouver

Borghi F, Laus A, Sorbi C, Rastelli G. Purine and Pyrrolopyrimidine‐Based Small Molecules as Multitarget Therapeutics. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70296

BibTeX
@article{Borghi2026,
  author = {Borghi, Federica and Laus, Antonio and Sorbi, Claudia and Rastelli, Giulio},
  title = {Purine and Pyrrolopyrimidine‐Based Small Molecules as Multitarget Therapeutics},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {6},
  doi = {10.1002/ardp.70296}
}
Kostenlos starten →